Sullivan Lara
Insider CIK 1769457 · RNN Director · PYXS President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2025-03-31 | 2025-04-02 | 918,308 | $0.98 | $899.9K | 918,308 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2024-12-23 | 2024-12-23 | 1,135,000 | — | $0 | 1,135,000 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2024-03-26 | 2024-03-28 | 1,071,242 | $3.83 | $4.10M | 1,071,242 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2023-09-18 | 2023-09-18 | 8,541 | $2.10 | $17.9K | 2,403,882 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2023-09-14 | 2023-09-18 | 100 | $2.25 | $225 | 2,412,423 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | F Tax w/h | 2023-09-13 | 2023-09-13 | 184,742 | $2.13 | $393.5K | 2,412,523 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2023-09-13 | 2023-09-13 | 3,000 | $2.27 | $6.8K | 2,597,265 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2023-09-12 | 2023-09-13 | 4,917 | $2.25 | $11.1K | 2,600,265 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2023-09-11 | 2023-09-13 | 20,000 | $2.27 | $45.4K | 2,605,182 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2023-09-07 | 2023-09-08 | 469,483 | — | $0 | 2,625,182 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2023-03-24 | 2023-03-28 | 61,825 | — | $0 | 61,825 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2023-03-24 | 2023-03-28 | 990,461 | — | $0 | 990,461 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | D To issuer deriv | 2023-03-24 | 2023-03-28 | 61,825 | — | $0 | 0 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | D To issuer deriv | 2023-03-24 | 2023-03-28 | 990,461 | — | $0 | 0 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2023-03-24 | 2023-03-28 | 703,379 | — | $0 | 2,155,699 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2023-01-03 | 2023-01-03 | 95,684 | — | $0 | 1,452,320 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2022-04-14 | 2022-04-15 | 315,273 | — | $0 | 1,356,636 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2022-03-31 | 2022-04-04 | 742,574 | — | $0 | 1,041,363 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2021-10-07 | 2021-10-12 | 962,289 | — | $0 | 962,289 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2019-06-06 | 2019-06-07 | 3,537 | — | $0 | 3,537 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2019-02-27 | 2019-03-01 | 84,968 | — | $0 | 84,968 | SEC↗ |